Prevalence of Hearing Loss and Tinnitus in a Group of Adults with Human Immunodeficiency Virus

Overview

Journal S Afr J Commun Disord

Specialty Otorhinolaryngology

Date 2020 Mar 5

PMID 32129664

Citations 4

Authors

Alison Millar

Karin Joubert

Alida Naude

Affiliations

Soon will be listed here.

Abstract

Background: The Human Immunodeficiency Virus (HIV) has become a global pandemic. With the improvement of antiretroviral (ARV) treatment regimens, life-expectancy of HIV-positive individuals has increased. HIV literature suggests that head and neck manifestations may be the first indication of supressed immunity. Therefore, research regarding the effects of HIV and new treatment regimens on auditory function remains a priority.

Objectives: To describe the audiological characteristics and determine the prevalence of hearing loss and tinnitus in a group of HIV-positive individuals on ARV treatment residing in a rural province.

Methods: The study employed a cross-sectional descriptive research design. Participants were recruited from the clinic and pharmacy waiting areas of a medical centre in a rural area of Limpopo province, South Africa. Two participant groups, an HIV-positive group (N1 = 60) and an HIV-negative group (N2 = 32) were included in the study. The test battery comprised a comprehensive case history and a routine audiological test battery, which included otoscopy, tympanometry and pure tone audiometry (250 Hz to 8000 Hz).

Results: No statistically significant difference was found regarding the prevalence of hearing loss in the two participant groups (p = 0.709). However, the prevalence of tinnitus was significantly higher in the HIV-positive group (p = 0.05).

Conclusion: The insignificant difference in the audiological test battery results found between the two participant groups may be due to improved ARV treatment regimens and management strategies employed at the medical centre. However, the increased prevalence of tinnitus in the HIV-positive group may also be attributed to the ARV regimen and/or the result of subtle damage to the auditory system, which was not identified by the current audiological test battery. More insight may be obtained about the effects of HIV on hearing by employing a longitudinal research design and inclusion of a more ototoxicity sensitive test battery.

Citing Articles

Clinical and audiological characteristics in adults with tinnitus in South Africa.

Khoza-Shangase K, Mkhize S S Afr J Commun Disord. 2024; 71(1):e1-e11.

PMID: 39625085 PMC: 11622119. DOI: 10.4102/sajcd.v71i1.1069.

An Analysis of Risk Factors for Hearing Function in Adults Living with Human Immunodeficiency Virus in Gauteng, South Africa.

Sebothoma B Indian J Otolaryngol Head Neck Surg. 2024; 76(2):1637-1644.

PMID: 38566657 PMC: 10982266. DOI: 10.1007/s12070-023-04375-z.

Functioning Problems Associated with Health Conditions with Greatest Disease Burden in South Africa: A Scoping Review.

Charumbira M, Berner K, Louw Q Int J Environ Res Public Health. 2022; 19(23).

PMID: 36497710 PMC: 9735592. DOI: 10.3390/ijerph192315636.

Investigation of the Interaction between Hearing Function and Comorbidities in Adults Living with Human Immunodeficiency Virus.

Sebothoma B, Khoza-Shangase K Int J Environ Res Public Health. 2021; 18(22).

PMID: 34831932 PMC: 8623667. DOI: 10.3390/ijerph182212177.

References

Brittz M, Heinze B, Mahomed-Asmail F, Swanepoel D, Stoltz A . Monitoring Hearing in an Infectious Disease Clinic with mHealth Technologies. J Am Acad Audiol. 2018; 30(6):482-492. DOI: 10.3766/jaaa.17120. View

Iacovou E, Vlastarakos P, Papacharalampous G, Kampessis G, Nikolopoulos T . Diagnosis and treatment of HIV-associated manifestations in otolaryngology. Infect Dis Rep. 2014; 4(1):e9. PMC: 3892662. DOI: 10.4081/idr.2012.e9. View

Mata Castro N, Yebra Bango M, Tutor de Ureta P, Villarreal Garcia-Lomas M, Lopez F . [Hearing loss and human immunodeficiency virus infection. Study of 30 patients]. Rev Clin Esp. 2000; 200(5):271-4. View

Khoza K, Ross E . Auditory function in a group of adults infected with HIV/AIDS in Gauteng, South Africa. S Afr J Commun Disord. 2004; 49:17-27. View

Jerger J . Clinical experience with impedance audiometry. Arch Otolaryngol. 1970; 92(4):311-24. DOI: 10.1001/archotol.1970.04310040005002. View

Heinze B, Swanepoel D, Hofmeyr L . Systematic review of vestibular disorders related to human immunodeficiency virus and acquired immunodeficiency syndrome. J Laryngol Otol. 2011; 125(9):881-90. DOI: 10.1017/S0022215111001423. View

Kakuda T . Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther. 2000; 22(6):685-708. DOI: 10.1016/S0149-2918(00)90004-3. View

Zuniga J . Communication disorders and HIV disease. J Int Assoc Physicians AIDS Care. 2001; 5(4):16-23. View

Marra C, Wechkin H, Longstreth Jr W, Rees T, Syapin C, Gates G . Hearing loss and antiretroviral therapy in patients infected with HIV-1. Arch Neurol. 1997; 54(4):407-10. DOI: 10.1001/archneur.1997.00550160049015. View

10.

. Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. Executive summary. April 2002. IAPAC Mon. 2002; 8(6):168-75. View

11.

Piot P, Quinn T . Response to the AIDS pandemic--a global health model. N Engl J Med. 2013; 368(23):2210-8. PMC: 3777557. DOI: 10.1056/NEJMra1201533. View

12.

Schouten J, Lockhart D, Rees T, Collier A, Marra C . A prospective study of hearing changes after beginning zidovudine or didanosine in HIV-1 treatment-naïve people. BMC Infect Dis. 2006; 6:28. PMC: 1402303. DOI: 10.1186/1471-2334-6-28. View

13.

. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992; 41(RR-17):1-19. View

14.

Khoza-Shangase K . Highly active antiretroviral therapy: Does it Sound toxic?. J Pharm Bioallied Sci. 2011; 3(1):142-53. PMC: 3053512. DOI: 10.4103/0975-7406.76494. View

15.

Chandrasekhar S, Connelly P, Brahmbhatt S, Shah C, Kloser P, Baredes S . Otologic and audiologic evaluation of human immunodeficiency virus-infected patients. Am J Otolaryngol. 2000; 21(1):1-9. DOI: 10.1016/s0196-0709(00)80117-9. View

16.

Prasad H, Bhojwani K, Shenoy V, Prasad S . HIV manifestations in otolaryngology. Am J Otolaryngol. 2006; 27(3):179-85. DOI: 10.1016/j.amjoto.2005.09.011. View

17.

Joubert K, Botha D . Contributing factors to high prevalence of hearing impairment in the Elias Motsoaledi Local Municipal area, South Africa: A rural perspective. S Afr J Commun Disord. 2019; 66(1):e1-e7. PMC: 6407449. DOI: 10.4102/sajcd.v66i1.611. View

18.

Cohen H, Cox C, Springer G, Hoffman H, Young M, Margolick J . Prevalence of abnormalities in vestibular function and balance among HIV-seropositive and HIV-seronegative women and men. PLoS One. 2012; 7(5):e38419. PMC: 3364989. DOI: 10.1371/journal.pone.0038419. View

19.

van der Westhuizen Y, Swanepoel D, Heinze B, Hofmeyr L . Auditory and otological manifestations in adults with HIV/AIDS. Int J Audiol. 2012; 52(1):37-43. DOI: 10.3109/14992027.2012.721935. View

20.

Zingler V, Cnyrim C, Jahn K, Weintz E, Fernbacher J, Frenzel C . Causative factors and epidemiology of bilateral vestibulopathy in 255 patients. Ann Neurol. 2007; 61(6):524-32. DOI: 10.1002/ana.21105. View